期刊文献+

骨髓和脾脏中单核细胞形成破骨细胞能力的对比研究 被引量:4

Comparison of the ability of forming osteoclasts of monocytes in bone marrow and spleen
下载PDF
导出
摘要 目的:比较骨髓及脾脏中单核细胞在体外培养过程中相互融合形成破骨细胞的能力。方法:采用新生大鼠颅盖骨消化法培养成骨细胞,再加入细胞因子、脾细胞、骨髓细胞,刺激单核细胞向破骨细胞的分化。结果:骨髓细胞组单核细胞融合形成破骨细胞的时间早于脾细胞组,而且破骨细胞的数量也较脾细胞组多,并有统计学意义。结论:骨髓细胞中单核细胞融合形成破骨细胞的能力强于脾细胞中单核细胞的融合能力。 AIM:To compare the ability of forming osteoclasts of monocytes in bone marrow and spleen in vitro cell culture.METHODS:The calvarian bone of new born rats was digested and cultured.Then the cytokine,spleen cells and bone marrow cells were added to stimulate the monocytes to form osteoclasts.RESULTS:Not only the period of monocytes of the marrow cell team forming osteoclasts is shorter than the spleen cell team,but the number of osteoclasts is also more.CONCLUSION:The ability of monocytes of bone marrow forming osteoclasts is more powerful than that in spleen .
出处 《牙体牙髓牙周病学杂志》 CAS 2005年第7期369-372,共4页 Chinese Journal of Conservative Dentistry
关键词 骨髓 单核细胞 破骨细胞 bone marrow spleen monocyte osteoclast
  • 相关文献

参考文献7

  • 1Yamane T, Kunisada T, Yamazaki H, et al. Sequential requirements for SCL/tal - 1, GATA -2, macrophage colony -stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development[ J]. Exp Hematol,2000 ,28 :833 - 840
  • 2Martin TJ. Paracrine regulation of osteoclast formation and activity: milestones in discovery [ J ]. J Musculoskelet Neuronal Interact,2004,4 ( 3 ) :243 - 53
  • 3Thomas GP, Baker SUK, Eisman JA, et al. Changing RANKL/OPGmRNA expression in differentiating murine primary osteoblasts[ J]. J Endocrinology,2001,170:45124601
  • 4白玉娣,杨富生.核因子κB受体活化剂研究进展[J].牙体牙髓牙周病学杂志,2003,13(7):415-417. 被引量:2
  • 5Mori SA. Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice[ J]. J Bone Miner Metab,2005,23(1):8-14
  • 6于世凤,李斌斌.破骨细胞与颌骨骨吸收研究展望[J].牙体牙髓牙周病学杂志,2003,13(7):357-360. 被引量:7
  • 7Sohara Y, Shimada H. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells [ J ]. Cancer Res,2005,65 (4): 1129 - 35

二级参考文献23

  • 1赵宁侠,于世凤,庞淑珍.Ⅱ型碳酸酐酶阻断剂抑制MGC体外骨吸收研究[J].中国骨质疏松杂志,1998,4(2):24-26. 被引量:2
  • 2史凤芹,于世凤,庞淑珍.分离的破骨细胞对不同钙化组织吸收的研究[J].中华口腔医学杂志,1994,29(6):346-347. 被引量:5
  • 3[11]Darnay BG, Ni J, Moore PA, et al. Activation of NF-κR bv RANK requires tumor necrosis factor receptor - associated factor(TRAF)6 and NF- κB- inducing kinase. Identification ofa TRAF6 interaction motiff[ J ]. J Bio Chem , 1999,274:7724
  • 4[12]Lacey DL, Tinms E, Tan H. - L,et al. Osteoprotegerin Ligand is a cytokine that regulates osteoclast differentiation and activation [ J ]. Cell, 1998,93:165
  • 5[13]H ofbauer LC, Khosla S, Lacey DL,et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption [ J ]. J Bone Miner Res , 2000,15:2
  • 6[14]Nakashima T, Kobayashi Y, Yamasaki S,et al. Protein expression and functional difference of membrane- bound and solublereceptor activator of NF - kappa B ligand: modulation of the expression by osteotropic factors and cytokines [ J ]. Biochem Biophys Res Commun ,2000,275 ( 3 ) :768
  • 7[15]Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption[J]. Medscape Womens Health ,2000,5 ( 2 ) :5
  • 8[16]Shevde NK, Bendixen AC, Dienger KM,et al. Estrogens suppress RANK ligand - induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression[J]. Proc Natl Acad Sci USA,2000,97 ( 14 ): 7829
  • 9[17]Mukohyama H, Ransjo M, Taniguchi H,et al. The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase- activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK[J]. Biochm Biophys Res Commun ,2000 ,271:158
  • 10[18]Oyajobi BO, Anderson DM,Traianedes K,et al. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaBIgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy[J]. Cancer Res,2001,61 ( 6 ): 2572

共引文献7

同被引文献47

  • 1李斌斌,于世凤,庞淑珍.两种破骨细胞培养方法的比较及其吸收骨质的动态观察[J].北京大学学报(医学版),2005,37(5):536-541. 被引量:14
  • 2杜文喜,陈于东,童培建,潘杰.破骨细胞体外培养分化因素及其机制的研究进展[J].现代中西医结合杂志,2006,15(2):258-260. 被引量:4
  • 3吕明波,陈克明,刘兴炎.破骨细胞体外培养研究进展[J].国际骨科学杂志,2006,27(5):308-310. 被引量:9
  • 4ROODMAN G D.Cell biology of the osteoclast[J].J Exp Hematol,1999,27:1229 -1241.
  • 5ALDRIDGE S E,LENNARD T W,WILLIAMS J R,et al.Vascular endothelial growth factor receptors in osteoclast differentiation and function[J].J Biochem Biophys Res Commun,2005,335:793-798.
  • 6DUONG L T,RODAN G A.Regulation of osteoclast formation and function[J].J Reviews Endocr Metab Disord,2001,2 (1):95-104.
  • 7OWENS J M,GALLAGHER A C,CHAMBERS T J.Bone cells required for osteoclastic resorption but not for osteoclastic differentiation[J].J Biochem Biophys Res Commun,1996,222(2):225-229.
  • 8NAKAGAWA N,KINOSAKI M,YAMAGUCHI K,et al.RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis[J].J Biochem Biophys Res Commun,1998,253(2):395-400.
  • 9KANATANI M,SUGINOTO T,KANZAWA M,et al.High extracelluar calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells[J].J Biochem Biophys Res Commun,1999,261 (1):144-148.
  • 10LORGET F,KAMEL S,MENTAVERRI R,et al.High extracelluar calcium concentrations directly stimulate osteoclast apotosis[J].J Bicchem Biophys Res Commun,2000,268 (3):899-903.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部